blog | Attovia Therapeutics

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Attovia Therapeutics

Attovia Therapeutics (ATTO) Delivers Strong IPO Debut as Investors Reward Next-Generation Immunology Platform

Eric Friedman

Aug 5, 2026, 5:04:26 PM

IPOs, 2026, Attovia Therapeutics

Attovia Therapeutics (ATTO) Targets $200 Million IPO to Advance Next-Generation Biologics for Immune-Mediated Diseases

Eric Friedman

Jul 31, 2026, 3:12:40 PM

Attovia Therapeutics (NASDAQ: ATTO) has filed to raise approximately $200 million through an initial...

Subscribe to our Newsletter

Email

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.